The etiology of those cases of nonbacterial pneumonia that cannot be associated with the viruses of psittacosis and influenza, adenoviruses, or other well delineated agents, and in which cold hemagglutinins or streptococcus MG agglutinins often develop, has been a controversial subject. The possible role in this disease of an agent isolated by Eaton, Meiklejohn, van Herick and Talbot in 1941 from patients with primary atypical pneumonia (1) has been difficult to evaluate because of the agent's limited host range and technical problems in performing specific serologic tests with it. Eaton's agent can be propagated in embryonated hens' eggs, as demonstrated by production of pneumonia on passage to cotton rats (2) , but produces no apparent pathologic change in the chick embryo (2, 3) . Using a modification of the fluorescent antibody technique of Coons and Kaplan (4), Liu, Eaton and Heyl have provided both a means of localizing the antigens in the chick embryo and a method by which sera can le examined for fluorescent-stainable antibodies to Eaton's agent (3, 5) . Additional isolations of Eaton's agent from patients and demonstrations of fluorescent-stainable antibodies to it have been reported by Cook (6) and Chanock (7) and their associates, confirming and extending the observations of Eaton and Liu. The specificity of this fluorescent antibody reaction in terms of the etiology of the disease has been questioned (8) , however, since patients with primary atypical pneumonia may develop a number of nonspecific serologic responses (9) (10) (11) (12) (13) (14) (15) . Primary atypical pneumonia produced under experimental conditions in man would provide an ideal situation for comparison of these various serologic tests.
In 1944 the Commission on Acute Respiratory Diseases of the Armed Forces Epidemiological Board performed studies on the transmission of primary atypical pneumonia to human subjects, using sputa and throat washings from patients with the characteristic syndrome (16a-d). Among the volunteers inoculated, two distinct disease patterns were induced: 1) an illness with constitutional symptoms and physical and roentgenographic findings of primary atypical pneumonia, and 2) a minor respiratory illness with minimal constitutional symptoms and physical findings but without pulmonary infiltration. Two similar experiments were performed, those men developing primary atypical pneumonia in the first experiment serving as donors of inocula for the second. Most of the cases of primary atypical pneumonia andl a few cases of the milder respiratory illness were associated with rises of cold hemagglutinins. The study suggested the presence of a filtrable, transmissible agent associated with the induced disease, but none was isolated by methods then available.
Further information on the association of Eaton's agent with human disease has been afforded by application of Liu's techniques to preserved sera from participants in the above transmission studies. Significant rises of fluorescent-stainable antibodies to Eaton's agent occurred in the majority of inoculated volunteers' sera. The data obtained are presented in this report.
MATERIALS AND METHODS
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lung suspension by Dr. Chien Liu. The agent was propagated by amniotic stab inoculation of 14-day old chick embryos with 0.2 ml each of a 1: 5 dilution of seed material in brain-heart infusion broth (Difco) and 1 per cent bovine albumin (Armour). For the first two passages 1,000 U of penicillin was added per ml of lung suspension. After 5 days' incubation at 350 C, inoculated embryos were harvested without chilling, and the lungs and trachea of each were removed aseptically. Tissues were ground in 2 ml of the broth-bovine albumin mixture per specimen in a glass tissue grinder. The pooled crude suspension was divided into 1-to 2-ml aliquots, sealed in glass ampules, and stored at -70°C. Material used in the experiments to follow was from the sixth egg passage, having an infectivity titer of 106 EID., per 0.2 ml, as determined by methods described by Liu (3).
Eggs. White Leghorn eggs from a local source were used exclusively. These were placed in a commercialtype incubator-hatcher for 14 days and after inoculation were maintained in a humidified standard laboratory incubator.
Sera. Sera collected before and after inoculation (see Tables I and II , and References 16a-d) of the volunteers were stored at 4°C for 12 to 18 months before lyophilization. They were then kept at room temperature for about 8 years and were subsequently stored at 40 C. Sera from 70 of the original 78 participants were available for examination. Each specimen was reconstituted to the original volume by addition of 2 ml of sterile distilled water, and aliquots were removed for testing. Sera from patients with primary atypical pneumonia in the Cleveland area (18) , stored at -20°C since 1947, provided positive and negative control specimens. Results of previous titrations of these control sera have been published by Cook and co-workers (6) .
For the preparation of fluorescein isothiocyanate-con- 2) for 7 to 8 days to remove uncombined fluorescein, the labeled globulin solution was absorbed once each with acetone-extracted chick embryo and adult chicken lung powders (4) to remove nonspecific staining properties. The absorbed, conjugated globulin solution was stored at -25°C until needed.
Fluorescent microscopic equipment. The source of ultraviolet light was an AH-6 water-cooled mercury vapor lamp,2 filtered by a 2.5 cm path of 2.5 per cent CuSO4 5 H20 solution and a half-thickness Corning 5840 filter. A standard laboratory monocular microscope was employed, fitted with a cardioid dark field condenser and a double Wratten 2-A gelatin filter in the ocular.
Preparation of infected tissue for scruni titrations. Chick embryos were inoculated with stock virus suspension and harvested as described above. The thorax of each embryo was removed, placed in an individual rubberstoppered tube and quick-frozen in an ethanol-carbon dioxide ice bath. In a microtome cryostat3 4-it frozen sections of the lungs of each embryo were cut. These were examined for viral antigens by the indirect fluorescent antibody technique, with known positive human convalescent serum and goat antihuman fluorescein-conjugated globulin solution. Embryos showing maximal (4+) fluorescence of the bronchial epithelium in two or more foci were selected for future use. Series of such sections were prepared for titrations, dried at room temperature, and stored at 40 C until used (within 1 tlose positive were diluted in twofold increments to 1:1,280 for testing on the same day. Each serum dilution tube received a code number and was not further identified until completion of the titration experiments. In addition, all titrations were performed without knowledge by the observer of the volunteer's classifications. Indirect fluorescent antibody technique. The entire staining procedure was conducted at room temperature. Series of infected chick embryo lung sections were fixed in acetone for 10 minutes and dried at 360 C for 20 minutes. Each section was overlaid with one serum dilution for 30 minutes. Slides were washed with gentle agitation in buffered saline for 10 minutes, wiped dry except for the section, and a drop of goat antihuman fluorescein-conjugated globulin solution applied for 30 minutes. The slides were again washed in buffered saline and mounted in buffered glycerol. The sections were examined under a fluorescence microscope and the amount of fluorescence recorded as 1 to 4+. Titration endpoints were determined as those serum dilutions giving minimal (1+) fluorescence of the chick bronchial epithelium.
Titration and staining controls. Dilutions of 1: 10, 1: 100, and 1: 1,000 of a serum with a consistent titer of 1,280 were included in each series of titrations to indicate the range and reproducibility of positive reactions. In addition to the positive serum, the following controls were included in each series of titrations with identical processing: 1) the first and last sections from each consecutive series used, stained with a 1:10 dilution of positive control serum; 2) sections stained with the serum diluent (1: 20 fresh known-negative human serum in buffered saline) ; and 3) sections held in buffered saline during the serum-staining period.
RESULTS
Detailed reports of the original experiments, which were designed to evaluate the nature of the etiological factors and clinical characteristics of primary atypical pneumonia, have been published previously (16a-d). A brief summary of these experiments is included here, however, for its pertinence to the material to follow.
First experiment (Table I) . Pooled sputa and throat washings from 6 patients with primary atypical pneumonia were divided into 3 aliquots which were respectively autoclaved, filtered to remove bacteria, and retained untreated. Three groups of volunteers, totaling 37 individuals, each received one of the types of inocula by nasopharyngeal insufflation, those inoculated with autoclaved material serving as the control group. Ten cases of primary atypical pneumonia and 15 cases of an undifferentiated minor respiratory illness resulted. These findings were difficult to interpret because both disease syndromes occurred in the control group. A modified repetition of this study was performed for further evaluation.
.Sccond cxpcrbiiit' ( 'Tatd HI). inoculumin was obtahied from 6 of the more severe cases of primary atyl)ical pneumonia which had been induced in the first experiment, and aliquots were again autoclaved, filtered, and retained untreated. In addition to more rigorous isolation procedures, the inoculations were performed outdoors and on different days, beginning with the autoclaved material and concluding with the untreated pool. Table III . Sixty-eight per cent of those receiving filtered inocula and 65 per cent of those receiving untreated ilnocula developed fourfold or greater rises of fluorescent-stainable antibody. The mean antibody response of the former group was a 10-fold increase, while that of the latter was a 21.9-fold increase. It was previously noted that those men receiving filtered inocula had somewhat milder illnesses after longer incubation periods, which was thought to be due to a reduction of the inoculating dose occasioned by the filtration procedure (16c) ( Tables I and II) .
In the first transmission experiment, three cases of primary atypical pneumonia and one of minor respiratory illness developed in the group receiving autoclaved inoculum. These unexpected illnesses were clinically and serologically identical with those induced in volunteers given active (filtered and untreated) inocula (Tables I and  II ). In view of the absence of apparent disease in the control group of the second experiment, it was felt that the illnesses in the first instance were produced by inadvertent infection rather than by stimulation of a theoretical latent agent by the inoculation procedure (16b). Possible mechanisms involved have been previously discussed (16b), and included contamination of the airpump used for inisufflation of inocula, airborne spread at the time of inoculation, or cross-infection after inoculation. The second possibility was favored by the occurrence of primary atypical pneumonia in an attendant and two members of the professional staff involved.
Since inadvertent infection apparently occurred in the first control group, this has been excluded from the comparative data to be presented. Of the 17 control subjects with available sera from the second experiment, 3 developed 2-fold anti- (Table IV) . These included 7 of 11 cases of primary atypical pneumonia and 14 of 20 cases of minor respiratory illness occurring in the two transmission experiments. Seven of 11 men who remained well after 6 with minor respiratory illness, and 1 with primary atypical pneumonia.
DISCUSSION
Although the identity of the infectious agent involved in the experiments is unknown, the rises in titer of fluorescent-stainable antibody to the Eaton agent were striking. Interpretation of the data is complicated by the present lack of knowledge of the nature of these fluorescent-stainable antibodies. Patients with primary atypical pneumonia may develop a variety of abnormal serologic reactions during convalescence: agglutinins for group 0 erythrocytes in the cold; agglutinins for streptococcus MG; complement-fixing reactions for various heterologous tissue antigens; and even false serologic tests for syphilis (8) (9) (10) (11) (12) (13) (14) (15) . Liu and associates, by means of cross-absorption experiments, demonstrated that the fluorescent-stainable antibodies are distinct from cold hemagglutinins and streptococcus MG agglutinins (5). The antigen-fluorescent-stainable antibody reaction does not bind complement but is enhanced by the presence of a heat-labile factor in normal fresh serum (5, 24) . Except in rare instances (25) , sera containing these antibodies fail to neutralize Eaton's agent in eggs; but Eaton has shown that sera of patients with primary atypical pneumonia may neutralize the agent, as indicated by prevention of pneumonia in cotton rats or hamsters inoculated with serum-virus mixtures (26, 27) . Results of both fluorescent-stainable antibody titrations and cotton rat neutralization titrations on the same sera reveal a close correlation in development of the two (5, 28 
